Brain 18F-DOPA PET/CT in the diagnosis of Parkinson’s disease
Annals of Clinical and Experimental Neurology · 30.03.2026 · 20 (1) · 76-81
DOI: 10.17816/acen.1469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Experimental Neurology, online erschienen am 30.03.2026. Verfasst von Sergey N. Illarioshkin und 8 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We retrospectively analyzed data from 5 patients with a clinically established diagnosis of Parkinson’s disease (PD) who underwent positron emission tomography combined with computed tomography (PET/CT) of the brain using the 18F-DOPA radiopharmaceutical. The study included quantitative assessment of tracer uptake — SUVr in the anterior and posterior parts of the putamen, as well as visual assessment of asymmetry and hypometabolism patterns. In all clinical cases included in the analysis, we recorded a significant reduction in tracer uptake in the projection of the putamen compared to healthy controls, which directly reflects progressive loss of dopaminergic neurons. All examined patients exhibited patterns characteristic of PD: a posterior-to-anterior gradient of involvement (most pronounced reduction in SUVr in the posterior putamen) and asymmetry of nigrostriatal degeneration. The side with more pronounced reduction in tracer uptake was generally contralateral to the side with more severe clinical symptoms. In the patient with a PRKN gene mutation, marked, nearly symmetric reduction in tracer uptake was recorded.
Zitieren
APA
Illarioshkin, S. N., Andreev, M. N., Liaskovik, A. A., Krasnov, M. Y., Fedotova, E. Y., Dvoynikov, S. Y., Tulina, L. M., Nikolaev, A. E., & Tyurin, A. V. (2026). Brain 18F-DOPA PET/CT in the diagnosis of Parkinson’s disease. Annals of Clinical and Experimental Neurology, 20(1), 76-81. https://doi.org/10.17816/acen.1469
Vancouver
Illarioshkin SN, Andreev MN, Liaskovik AA, Krasnov MY, Fedotova EY, Dvoynikov SY, et al. Brain 18F-DOPA PET/CT in the diagnosis of Parkinson’s disease. Annals of Clinical and Experimental Neurology. 2026;20(1):76-81. doi:10.17816/acen.1469
BibTeX
@article{Illarioshkin2026,
author = {Illarioshkin, Sergey N. and Andreev, Maksim N. and Liaskovik, Alina A. and Krasnov, Maksim Yu. and Fedotova, Ekaterina Yu. and Dvoynikov, Sergey Yu. and Tulina, Larisa M. and Nikolaev, Alexander E. and Tyurin, Anton V.},
title = {Brain 18F-DOPA PET/CT in the diagnosis of Parkinson’s disease},
journal = {Annals of Clinical and Experimental Neurology},
year = {2026},
volume = {20},
number = {1},
pages = {76--81},
doi = {10.17816/acen.1469}
}
EUVIMED